Filing Details

Accession Number:
0001179110-14-006340
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-04-02 19:29:05
Reporting Period:
2013-11-07
Filing Date:
2014-04-02
Accepted Time:
2014-04-02 19:29:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1061027 Sunesis Pharmaceuticals Inc SNSS Pharmaceutical Preparations (2834) 943295878
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1289884 B Steven Ketchum C/O Sunesis Pharmaceuticals, Inc.
395 Oyster Point Blvd., Suite 400
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-07 19,551 $2.09 93,512 No 4 M Direct
Common Stock Disposition 2013-11-07 19,551 $5.03 73,961 No 4 S Direct
Common Stock Acquisiton 2013-11-08 10,503 $2.09 84,464 No 4 M Direct
Common Stock Disposition 2013-11-08 10,503 $5.08 73,961 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-11-07 19,551 $0.00 19,551 $2.09
Commono Stock Common Stock Disposition 2013-11-08 10,503 $0.00 10,503 $2.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
92,948 2021-06-29 No 4 M Direct
82,445 2021-06-29 No 4 M Direct
Footnotes
  1. Includes 5,265 ESPP shares purchased on November 30, 2011.
  2. One forty-eighth (1/48th) of the option shares vest monthly over four (4) years from 6/30/11.
  3. The number of shares left in the option grant reflects the cancellation of 337,501 shares on 6/30/12 as a result of the reporting person's termination as an employee.